Ackman Brings Allergan To Court Over Poison Pill

By Karlee Weinmann (June 13, 2014, 11:41 AM EDT) -- Bill Ackman's Pershing Capital Management LP on Friday asked the Delaware Chancery Court to confirm that his plan to call a special meeting of Allergan Inc. shareholders won't trigger a poison pill meant to insulate the target company from the fund's $53 billion buyout campaign....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!